PROF vs RVTY · rev $10.7M vs P/E 42, rev $1.44B
Profound Medical Corp (PROF) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
PROF currently screens at market cap $238.7M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the PROF and RVTY stock pages for the full models.
Not investment advice.